SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    2.0 Recommendations and auditable outcomes, HIV Medicine, 2014, 15,
  2. 2
    J. P. Anderson, E. J. Tchetgen Tchetgen, V. Lo Re, J. P. Tate, P. L. Williams, G. R. Seage, C. R. Horsburgh, J. K. Lim, M. B. Goetz, D. Rimland, M. C. Rodriguez-Barradas, A. A. Butt, M. B. Klein, A. C. Justice, Antiretroviral Therapy Reduces the Rate of Hepatic Decompensation Among HIV- and Hepatitis C Virus-Coinfected Veterans, Clinical Infectious Diseases, 2014, 58, 5, 719

    CrossRef

  3. You have free access to this content3
    British HIV Association guidelines for the management of HIV infection in pregnant women 2012 (2014 interim review), HIV Medicine, 2014, 15,
  4. 4
    Kate Rowley, Brendan A.I. Payne, Matthias L. Schmid, Determinants of response to repeat hepatitis B vaccination in HIV-infected prior non-responders, Journal of Infection, 2014, 69, 1, 98

    CrossRef

  5. 5
    Philippa C. Matthews, Anna Maria Geretti, Philip J.R. Goulder, Paul Klenerman, Epidemiology and impact of HIV coinfection with Hepatitis B and Hepatitis C viruses in Sub-Saharan Africa, Journal of Clinical Virology, 2014, 61, 1, 20

    CrossRef

  6. 6
    Jennifer Y. Chen, Eoin R. Feeney, Raymond T. Chung, HCV and HIV co-infection: mechanisms and management, Nature Reviews Gastroenterology & Hepatology, 2014, 11, 6, 362

    CrossRef

  7. 7
    Tamer Abdelrahman, Joseph Hughes, Janice Main, John McLauchlan, Mark Thursz, Emma Thomson, Next-generation sequencing sheds light on the natural history of hepatitis C infection in patients who fail treatment, Hepatology, 2014, 60, 6
  8. 8
    Lay Lay Win, Paul James, David K. Wong, Response-Guided Therapy for Hepatitis C Genotype 2 and 3 in Those with HIV Coinfection, Digestive Diseases and Sciences, 2014, 59, 8, 1946

    CrossRef

  9. 9
    A. A. Farias, L. E. Kremer, L. Allende, M. d. P. Diaz, M. B. Pisano, M. S. Contigiani, V. E. Re, Determinants of immunological and virological responses to antiretroviral therapy amongst HIV-infected adults in central Argentina: negative influence of hepatitis C infection, Transactions of the Royal Society of Tropical Medicine and Hygiene, 2013, 107, 7, 432

    CrossRef

  10. 10
    Sara A Healy, Sonia Gupta, Ann J Melvin, HIV/HBV coinfection in children and antiviral therapy, Expert Review of Anti-infective Therapy, 2013, 11, 3, 251

    CrossRef

  11. 11
    Rachel M. Brown, Stefan G. Hübscher, Infectious diseases of the hepatobiliary system, Diagnostic Histopathology, 2013, 19, 3, 80

    CrossRef

  12. 12
    Michelle C.M. Cheung, Kosh Agarwal, Liver abnormalities in the immunosuppressed, Best Practice & Research Clinical Gastroenterology, 2013, 27, 4, 597

    CrossRef

  13. 13
    H. Gatanaga, T. Hayashida, J. Tanuma, S. Oka, Prophylactic Effect of Antiretroviral Therapy on Hepatitis B Virus Infection, Clinical Infectious Diseases, 2013, 56, 12, 1812

    CrossRef

  14. 14
    Kate Childs, Deepak Joshi, Ruth Byrne, Matthew Bruce, Ivana Carey, Kosh Agarwal, Chris Taylor, Tenofovir-based combination therapy for HIV/HBV co-infection, AIDS, 2013, 27, 9, 1443

    CrossRef

  15. 15
    Kristen Brown, Martin LaBrie, Carla S. Coffin, Treatment of Genotype 2 and Genotype 3 Hepatitis C Virus (HCV) Infection in Human Immunodeficiency Virus Positive Patients, Current HIV/AIDS Reports, 2013, 10, 4, 420

    CrossRef

  16. You have free access to this content16
    11.0 References, HIV Medicine, 2012, 13,
  17. You have free access to this content17
    2.0 Recommendations and auditable outcomes, HIV Medicine, 2012, 13,
  18. You have free access to this content18
    6.0 HIV and hepatitis virus coinfections, HIV Medicine, 2012, 13,
  19. You have free access to this content19
    8.0 Antiretroviral therapy in specific populations, HIV Medicine, 2012, 13,
  20. 20
    Ziba Jalali, Jürgen K. Rockstroh, Antiviral Drugs and the Treatment of Hepatitis C, Current HIV/AIDS Reports, 2012, 9, 2, 132

    CrossRef

  21. You have free access to this content21
    GP Taylor, P Clayden, J Dhar, K Gandhi, Y Gilleece, K Harding, P Hay, J Kennedy, N Low-Beer, H Lyall, A Palfreeman, P Tookey, S Welch, E Wilkins, A de Ruiter, British HIV Association guidelines for the management of HIV infection in pregnant women 2012, HIV Medicine, 2012, 13,
  22. 22
    Shuangjie Zhang, Ard van Sighem, Anouk Kesselring, Luuk Gras, Colette Smit, Jan M. Prins, Robert Kauffmann, Clemens Richter, Frank de Wolf, Peter Reiss, Episodes of HIV Viremia and the Risk of Non-AIDS Diseases in Patients on Suppressive Antiretroviral Therapy, JAIDS Journal of Acquired Immune Deficiency Syndromes, 2012, 60, 3, 265

    CrossRef

  23. 23
    G. Wandeler, T. Gsponer, A. Bregenzer, H. F. Gunthard, O. Clerc, A. Calmy, M. Stockle, E. Bernasconi, H. Furrer, A. Rauch, Hepatitis C Virus Infections in the Swiss HIV Cohort Study: A Rapidly Evolving Epidemic, Clinical Infectious Diseases, 2012, 55, 10, 1408

    CrossRef

  24. 24
    Linda Aurpibul, Pagakrong Lumbiganon, Pope Kolasaraksa, Rawiwan Hansudewechakul, Pattaratida Sa-nguanmoo, Pawinee Taeprasert, Torsak Bunupuradah, Yong Poovorawan, Virat Sirisanthana, Thanyawee Puthanakit, HIV and Hepatitis B Coinfection Among Perinatally HIV-infected Thai Adolescents, The Pediatric Infectious Disease Journal, 2012, 31, 9, 943

    CrossRef

  25. You have free access to this content25
    NJ Beeching, R Jones, B Gazzard, 4 Gastrointestinal opportunistic infections, HIV Medicine, 2011, 12,
  26. 26
    Sanjay Bhagani, Current treatment for chronic hepatitis C virus/HIV-infected individuals, Current Opinion in HIV and AIDS, 2011, 6, 6, 483

    CrossRef

  27. 27
    E. Angeli, A. Mainini, P. Meraviglia, M. Schiavini, E. Ricci, R. Giorgi, G. Gubertini, G. Rizzardini, Eligibility and Feasibility of the Treatment of Chronic Hepatitis C in a Cohort of Italian HIV-Positive Patients at a Single HIV Reference Center, AIDS Patient Care and STDs, 2011, 25, 5, 295

    CrossRef

  28. 28
    Gail V. Matthews, Prince Manzini, Zonghui Hu, Paul Khabo, Patrick Maja, Gugu Matchaba, Phumele Sangweni, Julie Metcalf, Nicholaas Pool, Susan Orsega, Sean Emery, Impact of lamivudine on HIV and hepatitis B virus-related outcomes in HIV/hepatitis B virus individuals in a randomized clinical trial of antiretroviral therapy in southern Africa, AIDS, 2011, 25, 14, 1727

    CrossRef

  29. 29
    Deepak Joshi, John O'Grady, Doug Dieterich, Brian Gazzard, Kosh Agarwal, Increasing burden of liver disease in patients with HIV infection, The Lancet, 2011, 377, 9772, 1198

    CrossRef

  30. 30
    Kalyan Ram Bhamidimarri, James Park, Douglas Dieterich, Management of Hepatitis B Virus Coinfection: HIV, Hepatitis C Virus, Hepatitis D Virus, Current Hepatitis Reports, 2011, 10, 4, 262

    CrossRef

  31. 31
    Libuše Ratcliffe, Michael BJ Beadsworth, Ashley Pennell, Matthew Phillips, Francisco J Vilar, Managing hepatitis B/HIV co-infected: adding entecavir to truvada (tenofovir disoproxil/emtricitabine) experienced patients, AIDS, 2011, 25, 8, 1051

    CrossRef

  32. 32
    J Rockstroh, G Guaraldi, G Deray, HIV and the body: a review of multidisciplinary management, HIV Medicine, 2010, 11,
  33. 33
    Debasish Basu, Overview of Substance Abuse and Hepatitis C Virus Infection and Co-infections in India, Journal of Neuroimmune Pharmacology, 2010, 5, 4, 496

    CrossRef

  34. 34
    Deirdre A. Kelly, C.Y. William Tong, Neonatal and Pediatric Infection,
  35. 35
    Quentin M. Anstee, Janice Main, New Challenges of the NAFLD and HIV Epidemics,